Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1997-10-06
2000-02-01
Priebe, Scott D.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
435 691, 4353201, 435325, 536 231, C07K 1600, C12N 1500
Patent
active
06020463&
ABSTRACT:
The present invention relates to methods and compositions for the treatment and diagnosis of cardiovascular disease, including, but not limited to, atherosclerosis, ischemia/reperfusion, hypertension, restenosis, and arterial inflammation. Specifically, the present invention identifies and describes genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. Further, the present invention identifies and describes genes via the ability of their gene products to interact with gene products involved in cardiovascular disease. Still further, the present invention provides methods for the identification and therapeutic use of compounds as treatments of cardiovascular disease. Moreover, the present invention provides methods for the diagnostic monitoring of patients undergoing clinical evaluation for the treatment of cardiovascular disease, and for monitoring the efficacy of compounds in clinical trials. Additionally, the present invention describes methods for the diagnostic evaluation and prognosis of various cardiovascular diseases, and for the identification of subjects exhibiting a predisposition to such conditions.
REFERENCES:
patent: 5202420 (1993-04-01), Zasloff et al.
patent: 5418162 (1995-05-01), Blakely et al.
patent: 5422262 (1995-06-01), Anderson et al.
Bartel et al., 1993, "Using the two-hybrid system to detect protein-protein interactions", Cellular Interactions in Dev. Chap.7, pp. 153-159.
Bird et al., 1988, "Single-chain antigen-binding proteins", Science 242:423-426.
Blachly-Dyson et al., 1993, "Cloning and functional expression in ueast of two human isoforms of the outer mitochondrial membrane channel, the voltage-dependent anion channel", J. Biol. Chem. 268:1835-1841.
Border & Noble, 1995, "Targeting TGF-.beta. for treatment of disease", Nature Med. 1:1000-1001.
Charles et al., 1993, "Genomic structure, cDNA sequence, and expression of gly96, a growth factor-inducible immediate-early gene encoding a short-lived glycosylated protein", Oncogene 8:797-801.
Chen et al., 1996, "A transcriptional partner for MAD proteins in TGF-.beta. signaling", Nature 383:691-696.
A. Coghlan, 1995, "Gene dream fades away", New Scientist:14-15.
Diamond et al., 1993, "Novel delayed-early and highly insulin-induced growth response genes", J. Biol. Chem. 268:15185-15192.
Eppert et al., 1996, "MADR2 maps to 18q21 and encodes a TGF.beta.-regulated MAD-related protein that is functionally mutated in colorectal carcinoma", Cell 86:543-552.
Grainger et al., 1995, "Tamoxifen elevates transforming growth factor-.beta. and suppresses diet-induced formation of lipid lesions in mouse aorta", Nature Med. 1:1067-1073.
T. Gura et al., 1995, "Estrogen: Key player in heart disease among women", Science 269:771-773.
Hochman et al., 1995, "Dissociation of synchronization and excitability in furosemide blockage of epileptiform activity", Science 270:99-102.
Hoodless et al., 1996, "MADR1, a MAD-related protein that functions in BMP2 signaling pathways", Cell 85:489-500.
Kojima et al., 1991, "Lipoprotein (a) inhibits the generation of transforming growth factor .beta.: An endogenous inhibitor of smooth muscle cell migration", J. Cell. Biol. 113:1439-1445.
F. Ledley, 1995, "Nonviral gene therapy: The promise of genes as pharmaceutical products",Human Gene Therapy6:1129-1144.
Li et al., 1991, "Early induction of an atherosclerosis-associated endothelial-leukocyte adhesion molecule (athero-ELAM) by an atherogenic diet in rabbits", Arterioscler. Thromb. 11:1397a.
E. Marshall, 1995, "Less hype, more biology needed for gene therapy".
E. Marshall, 1995, "Gene therapy's growing pains", Science 269:1050-1055.
Nikol et al., 1992, "Expression of transforming growth factor-.beta.1 is increased in human vascular restenosis lesions", J. Clin. Invest. 90:1582-1592.
Orkin & Motulsky, 1995, "Report and recommendations of the panel to assess the NIH investment in research on gene therapy", NIH Report.
Raftery et al., 1988, "Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila", Genetics 139:241-254.
Sambrook et al.(eds), 1989, "Estimating the Effects of Mismatches", Molecular Cloning--A Laboratory Manual 2.sup.nd Edition, p. 11.47.
Serra & Moses, 1996, "Tumor suppressor genes in the TGF-.beta. signaling pathway?", Nature Med. 2:390-391.
Shreeniwas et al., 1991, "Reoxygenation stimulates IL-1.alpha. production, increasing leukocyte adherence to endothelium via expression of ICAM-1 and ELAM-1", Arterioscler. Council Abstracts 11:1397a.
Simmons et al., 1988, "ICAM, and adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM", Nature 331:624-627.
Wallace & Miyada, 1987, "Oligonucleotide probes for the screening of recombinant DNA libraries", Methods in Enzymology 152:432-443.
Wieser et al., 1995, "GS domain mutation that constitutively activate T.beta.R-I, the downstream signaling component in the TGF-.beta. receptor complex", EMBO J. 14:2199-2208.
Wrana et al., 1994, "Mechanism of activation of the TGF-.beta. receptor", Nature 370:341-347.
Patrick Jr., et al., 1995, "Shear stress and cyclic strain moduclation of gene expression in vascular endothelial cells", Blood Purification 13:112-124.
Shyy et al., 1995, "Multiple cis-elements mediate shear stress-induced gene expression", J. Biomechanics 28:1451-1457.
Weatherall, D.J., 1995, "Scope and limitations of gene therapy", British Medic.
International Search Report, Application No. PCT/US97/02291, dated Jul. 11, 1997.
Harrison et al., 1993, "Molecular cloning of a novel rat G-protein-coupled receptor gene expressed prominently in lung, adrenal, and liver", FEBS Letters 318:17-22.
Falb Dean A.
Gimbrone, Jr. Michael A.
Brigham and Women's Hospital
Millennium Pharmaceuticals Inc.
Nguyen Daug Trong
Priebe Scott D.
LandOfFree
Compositions and methods for the treatment and diagnosis of card does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the treatment and diagnosis of card, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment and diagnosis of card will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-938661